Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Mr. Valmir Rastely-Junior | Infectious Diseases | Young Scientist Award

Universidade Federal da Bahia | Brazil

Mr. Valmir Rastely-Junior is a distinguished physician specializing in infectious diseases, pediatrics, and neuropediatrics, with an MD from the Federal University of Bahia (UFBA, 2015). He has accumulated extensive clinical and research experience, focusing on child health, congenital Zika syndrome, antimicrobial resistance, and public health inequities, integrating multidisciplinary care with evidence-based interventions. His professional trajectory includes work at Fiocruz Bahia on neurodevelopmental studies, epidemiologic surveillance, teratogen information services, and COVID-19 teleadvice programs. He has been instrumental in technology-driven initiatives such as Telecoronavírus (UFBA) and Artificial Intelligence as a Service for Combating COVID-19 (Rede CoVida/Cidacs Fiocruz), emphasizing the translation of research into practical, community-focused solutions. Mr. Rastely-Junior’s research interests center on infectious-disease–driven child health, neurodevelopmental outcomes in congenital infections, health disparities, and AI-supported clinical and epidemiological tools. He possesses strong research skills, including clinical study design, epidemiologic analysis, bibliometric synthesis, and international collaborative research, demonstrated through six peer-reviewed publications in Scopus and PubMed-indexed journals, three joint research projects, two conference presentations, and mentorship of research scholars. His work has earned eight awards and recognitions, including first-place honors at Fiocruz Bahia and an honorable mention in the International Balint Award/Ascona Prize, reflecting both scientific excellence and societal impact. Mr. Rastely-Junior is an active member of 16 professional bodies, contributing to editorial, review, and volunteer initiatives that promote knowledge dissemination and community engagement. In conclusion, his blend of clinical expertise, innovative research, international collaborations, and commitment to evidence-based public health positions him as a promising leader in global biomedical research, capable of advancing high-impact publications, AI-enabled solutions, and mentorship programs that enhance healthcare outcomes and scientific standards worldwide. 27 Citations | 3 Documents | 2 h-index.

Profiles: Google Scholar | Scopus | ORCID | LinkedIn

Featured Publications

  1. Aguilar Ticona, J. P., Nery Jr, N., Doss-Gollin, S., Gambrah, C., Lessa, M., … Rastely-Junior, V. N. (2021). Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly. PLoS One, 16(9), e0256444. https://doi.org/10.1371/journal.pone.0256444. Cited by: 26

  2. Nery Jr, N., Aguilar Ticona, J. P., Gambrah, C., Doss-Gollin, S., Aromolaran, A., … Rastely-Junior, V. N. (2021). Social determinants associated with Zika virus infection in pregnant women. PLoS Neglected Tropical Diseases, 15(7), e0009612. https://doi.org/10.1371/journal.pntd.0009612. Cited by: 14

  3. Aromolaran, A., Araujo, K., Ladines-Lim, J. B., Nery Jr, N., do Rosário, M. S., … Rastely-Junior, V. N. (2022). Unequal burden of Zika-associated microcephaly among populations with public and private healthcare in Salvador, Brazil. International Journal of Infectious Diseases, 120, 201–204. https://doi.org/10.1016/j.ijid.2022.06.021. Cited by: 6

  4. Mattos, A. M., Rastely-Junior, V. N., Pires, M. M., Aguilar, J. P., Lessa, M. S. A., Regis, C., … (2023). Predictors of neurodevelopment in microcephaly associated with congenital Zika Syndrome: A prospective study. Children, 10(12), 1831. https://doi.org/10.3390/children10121831. Cited by: 3

  5. Brito, L. B., Rastely-Junior, V. N., Browne, E. S., Nery Júnior, N. R. R., … (2016). Sinais e sintomas de zika-virus em gestantes internadas em um Hospital Público de referência da Bahia. Cited by: 2

 

Daniele Lages | Immunology and Microbiology | Best Researcher Award

Mrs . Daniele Lages | Immunology and Microbiology | Best Researcher Award

Doutoranda at Universidade Federal de Minas Gerais , Brazil

Daniele dos Santos Lages is a dedicated Brazilian researcher specializing in public health, with a focus on epidemiology, particularly related to leprosy (hanseníase). Her work combines academic rigor with social impact, addressing neglected diseases and strengthening primary healthcare systems. She is fluent in Portuguese, English, and Spanish, which allows her to collaborate across international boundaries. Daniele has received multiple academic honors, presented research at notable conferences, and published significant contributions on disease surveillance and public health policy. Her involvement in research groups, notably NEPHANS at UFMG, underlines her leadership in advancing public health research in Brazil. She has also completed various international and national health training programs, demonstrating a commitment to lifelong learning and capacity building. Daniele’s blend of academic achievement, research productivity, and social responsiveness positions her as an influential figure in public health, making her a strong candidate for recognition through research and academic excellence awards.

Professional Profile 

Education🎓

Daniele dos Santos Lages has pursued an outstanding academic path focused on nursing and public health at the Federal University of Minas Gerais (UFMG), one of Brazil’s top universities. She earned her bachelor’s degree in Nursing, followed by a specialization in Family Health (Residência Multiprofissional) from the same institution. She further advanced her academic qualifications by completing a Master’s degree and is currently a doctoral candidate in Nursing with a focus on Public Health at UFMG. Throughout her educational journey, she has consistently focused on public health issues, particularly in disease prevention and control, with a strong emphasis on leprosy. Her academic background is complemented by several national and international certifications in epidemiology, health surveillance, and neglected tropical diseases, many of which are issued by globally recognized bodies like WHO and PAHO. This combination of formal education and specialized training gives her a strong foundation for conducting impactful, evidence-based health research.

Professional Experience📝

Daniele has built a meaningful professional career around research and public health services, with an emphasis on leprosy control and primary healthcare strategies. She is an active member of the NEPHANS research group at UFMG, where she contributes to epidemiological studies, health surveillance analysis, and healthcare delivery systems. Her work includes data-driven policy evaluations and healthcare service assessments focused on vulnerable populations affected by neglected diseases. Daniele has authored and co-authored several academic papers and posters, many of which were presented at national and international conferences, receiving awards for scientific excellence. In addition to her research, she has participated in teaching, public health campaigns, and collaborative projects with health institutions and government agencies. Her hands-on experience with Brazil’s Unified Health System (SUS) has informed her practical understanding of public health challenges. By combining academic insight with field engagement, Daniele bridges the gap between theory and practice, making her contributions highly relevant and applicable.

Research Interest🔎

Daniele dos Santos Lages is deeply committed to advancing research in public health, with her primary focus on the epidemiology of neglected tropical diseases, particularly leprosy (hanseníase). Her academic and professional endeavors revolve around disease surveillance, healthcare accessibility, health equity, and the effectiveness of Brazil’s Unified Health System (SUS). Daniele is particularly interested in the social determinants of health, evaluating how poverty, education, and access to care affect disease prevalence and treatment outcomes. She explores the intersection of clinical practice and public policy to propose practical, evidence-based improvements in primary care. Her research integrates quantitative epidemiological data with qualitative insights from affected populations, aiming to inform public health strategies and reduce disease-related stigma. As a doctoral researcher, she is involved in multidisciplinary investigations that align with global health priorities and the Sustainable Development Goals, particularly those concerning the elimination of neglected diseases and the promotion of universal health coverage.

Award and Honor🏆

Daniele dos Santos Lages has been recognized multiple times for her academic excellence and impactful research in public health. Among her accolades, she received awards for the best oral presentation at national conferences, highlighting her effective communication and the societal relevance of her work. She has also been granted scholarships and research support through prestigious programs like PROBIC/FAPEMIG, affirming the merit of her scientific inquiries. Her participation in highly competitive international training programs hosted by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) further underscores her status as a distinguished emerging scholar. These programs focus on epidemiological intelligence, health surveillance, and strategies to combat neglected tropical diseases. Daniele’s consistent recognition reflects her commitment to scientific rigor, community health, and leadership within Brazil’s healthcare research community. These honors not only validate her contributions but also inspire her continued efforts to advance evidence-based practices in public health and epidemiology.

Research Skill🔬

Daniele dos Santos Lages possesses a robust set of research skills that equip her to address complex public health issues with analytical precision and social sensitivity. Her expertise spans epidemiological data analysis, qualitative and quantitative research design, health indicators assessment, and policy evaluation. She is proficient in statistical software and epidemiological tools used for surveillance and data interpretation, allowing her to derive actionable insights from large health datasets. Daniele also demonstrates strong competencies in scientific writing, grant proposal development, and knowledge translation for both academic and public audiences. She actively applies mixed-method approaches to explore healthcare access, disease distribution, and the effectiveness of Brazil’s health policies. In addition to technical skills, she excels in collaborative research, working across disciplines and institutions to contribute to national and international public health projects. Her fluency in Portuguese, English, and Spanish facilitates international collaboration, making her a versatile and globally relevant public health researcher.

Conclusion💡

Daniele dos Santos Lages exhibits exceptional promise and achievement as a public health researcher, particularly in the domain of leprosy surveillance and primary healthcare systems. Her strong academic background, dedication to neglected diseases, and proactive engagement in capacity-building initiatives mark her as a passionate and purpose-driven professional. Her research is not only scientifically relevant but socially responsive, aligning closely with global health equity goals. Although she would benefit from more diversified research themes and wider international exposure, her foundation is solid and future potential is significant. With continued interdisciplinary collaboration and publication in global platforms, Daniele is well-positioned to make substantial contributions to global public health. Therefore, she is a strong and deserving candidate for the Best Researcher Award, especially within categories that recognize early-career excellence, commitment to social determinants of health, and contributions to underrepresented health issues in vulnerable populations. Her work exemplifies the blend of academic rigor and societal relevance that such awards aim to honor.

Publications Top Noted✍️

  • Title: A baixa escolaridade está associada ao aumento de incapacidades físicas no diagnóstico de hanseníase no Vale do Jequitinhonha
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, FCF Lana
    Year: 2018
    Citations: 51

  • Title: Spatial analysis of the epidemiological risk of leprosy in the municipalities of Minas Gerais
    Authors: IC Bueno, DS Lages, FCF Lana
    Year: 2023
    Citations: 12

  • Title: Profile of the leprosy endemic in the district of Murrupula, Nampula, Mozambique: A population-based study
    Authors: GC Ribeiro, DS Lages, ATC Lages, VB Souza, A Marega, FCF Lana, …
    Year: 2023
    Citations: 4

  • Title: Consistência do registro dos casos de hanseníase no Sistema de Informação de Agravos de Notificação em Minas Gerais-período: 2017 a 2021
    Authors: GCS Reis, DS Lages, FCF Lana
    Year: 2024
    Citations: 2

  • Title: Avaliação do grau de incapacidade física por hanseníase em Minas Gerais
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, SL Vidal, …
    Year: 2022
    Citations: 2

  • Title: Spatial, Social and Serological Factors in the Prevalence and Risk of Leprosy in Areas of High Endemicity: An Integrative Review
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed (assumed 0 or pending)

  • Title: Análise da ocorrência de sífilis em gestantes em um município da Região Metropolitana de Belo Horizonte entre 2011 e 2021
    Authors: SL Dias, D dos Santos Lages, ICL Maciel, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: Correlation and Trends in Primary Health Care and Family Health Strategy Coverage of Leprosy Detection in Minas Gerais
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: An interrupted time series study of the leprosy case detection in Brazil after the COVID-19 pandemic
    Authors: GJB Sousa, DS Lages, PPL Barbosa, MCN Rocha, SA de Sena Neto, …
    Year: 2025
    Citations: Not listed

Shadi Hamoud | Heart diseases | Best Researcher Award

Dr. Shadi Hamoud | Heart diseases | Best Researcher Award

Head, research unit at Rambam Health Care Campus, Israel

Dr. Shadi Hamoud is a distinguished physician, researcher, and academic leader specializing in internal medicine, atherosclerosis, and novel cardiovascular treatments. With an MD (cum laude) from Hebrew University and an MPA from the University of Haifa, he serves as a Clinical Senior Lecturer at the Technion-Israel Institute of Technology and Deputy Director of Internal Medicine E at Rambam Medical Center. His research focuses on lipoproteins oxidation, heparanase enzyme roles in kidney and liver diseases, and international clinical trials on cardiovascular medicine, diabetes, and COVID-19 therapies. He has mentored numerous graduate students, contributed extensively to clinical research, and secured competitive research grants. His leadership extends to ethics committees, pharmaceutical consulting, and medical education. Recognized with multiple teaching excellence awards, he actively contributes to professional societies, public health initiatives, and medical advancements, making him a strong candidate for the Best Researcher Award. However, a broader international research collaboration could further enhance his impact.

Professional Profile

Education🎓

Dr. Shadi Hamoud holds an MD degree with cum laude honors from the Hebrew University of Jerusalem, demonstrating his strong academic foundation in medicine. He further pursued an Executive Master of Public Administration (MPA) at the University of Haifa, equipping him with leadership and administrative skills essential for medical research and healthcare management. Throughout his education, he developed a keen interest in internal medicine, atherosclerosis, and cardiovascular diseases, which later became the core of his research. His academic journey also includes specialized training in clinical research, medical ethics, and translational medicine, enhancing his expertise in both theoretical and practical aspects of healthcare. His commitment to continuous learning is evident in his involvement with international research projects and advanced training programs. His diverse educational background not only strengthens his medical proficiency but also enables him to contribute significantly to healthcare policy, medical education, and clinical advancements in cardiovascular and metabolic diseases.

Professional Experience 📝

Dr. Shadi Hamoud is a distinguished physician and researcher specializing in internal medicine, atherosclerosis, and cardiovascular diseases. He has extensive professional experience in clinical practice, medical research, and healthcare administration. As a senior physician, he has worked in leading hospitals, diagnosing and treating complex cardiovascular and metabolic disorders. His expertise extends to translational medicine, bridging the gap between research and patient care. Dr. Hamoud has also been actively involved in clinical trials, contributing to groundbreaking studies on lipid metabolism and atherosclerosis. His leadership roles in medical institutions and research committees reflect his dedication to advancing medical knowledge and improving patient outcomes. Additionally, he has collaborated with international experts, publishing numerous high-impact research papers in peer-reviewed journals. His commitment to medical education is evident through mentoring young researchers and medical students, ensuring the next generation of healthcare professionals is well-equipped to tackle emerging challenges in cardiovascular and metabolic diseases.

Research Interest🔎

Dr. Shadi Hamoud’s research interests focus on cardiovascular diseases, atherosclerosis, and lipid metabolism, with a particular emphasis on the mechanisms underlying cardiovascular risk factors. His work explores the role of cholesterol, inflammation, and metabolic disorders in the development of atherosclerosis, aiming to identify novel therapeutic targets for prevention and treatment. He is also deeply interested in translational medicine, bridging laboratory research with clinical applications to enhance patient care. Dr. Hamoud has contributed significantly to studies on lipid-lowering therapies, biomarkers for cardiovascular risk assessment, and the impact of lifestyle modifications on heart health. His research extends to the intersection of metabolic disorders such as diabetes and obesity with cardiovascular disease, seeking innovative strategies to reduce morbidity and mortality. Through collaborations with international research institutions, he continues to advance scientific understanding in cardiovascular medicine, striving to develop more effective diagnostic tools and personalized treatment approaches for patients with cardiovascular and metabolic diseases.

Award and Honor🏆

Dr. Shadi Hamoud has received numerous awards and honors in recognition of his outstanding contributions to cardiovascular research and medicine. His excellence in scientific innovation and dedication to improving cardiovascular health have earned him prestigious accolades from medical and research institutions worldwide. He has been honored with awards for his groundbreaking work in lipid metabolism and atherosclerosis, highlighting his impact on the field. Additionally, Dr. Hamoud has received research grants and fellowships that have supported his pioneering studies in cardiovascular disease prevention and treatment. His contributions have been recognized through invitations to speak at international conferences, where he has shared his expertise with the global medical community. He has also been acknowledged for his mentorship and leadership in guiding young researchers in the field. Through his achievements, Dr. Hamoud continues to make significant advancements in cardiovascular medicine, earning widespread recognition for his dedication to scientific excellence and patient care.

Research Skill🔬

Dr. Shadi Hamoud possesses exceptional research skills that have significantly advanced the field of cardiovascular medicine. His expertise spans a wide range of methodologies, including molecular biology techniques, lipid metabolism analysis, and advanced imaging technologies for cardiovascular assessment. He is proficient in designing and conducting clinical and laboratory-based studies, utilizing statistical tools to analyze complex datasets, and translating research findings into clinical applications. Dr. Hamoud excels in grant writing and securing research funding, demonstrating his ability to lead high-impact projects. His strong problem-solving skills and critical thinking enable him to address challenging scientific questions effectively. Additionally, his collaborative approach fosters interdisciplinary research, enhancing innovation in cardiovascular disease prevention and treatment. With a keen eye for detail and a commitment to scientific integrity, Dr. Hamoud consistently produces high-quality research that contributes to medical advancements, making him a highly respected figure in the scientific and medical communities.

Conclusion💡

Dr. Shadi Hamoud is a highly suitable candidate for the Best Researcher Award, given his exceptional contributions to cardiovascular research, clinical medicine, and medical education. His extensive mentorship, leadership in international clinical trials, and commitment to translational medicine make him a strong contender. Strengthening his global visibility and publishing more in top-tier journals could further enhance his profile.

Publications Top Noted✍️

  • Title: Potential Nephroprotective Effect of uPA against Ischemia/Reperfusion-Induced Acute Kidney Injury in αMUPA Mice and HEK-293 Cells
    Authors: H.A. Alkhaleq, Heba Abd; I. Hacker, Israel; T. Karram, Tony; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024

  • Title: Involvement of Heparanase in the Pathogenesis of Acute Pancreatitis: Implication of Novel Therapeutic Approaches
    Authors: D.B. Hamo-Giladi, Dalit B.; A. Fokra, Ahmad; E. Sabo, Edmond; Z.A. Abassi, Zaid A.; I. Khamaysi, Iyad
    Year: 2024

  • Title: Gender-Specific Renoprotective Pathways in αMUPA Transgenic Mice Subjected to Acute Kidney Injury
    Authors: H.A. Alkhaleq, Heba Abd; S. Hamoud, Shadi; I. Hacker, Israel; A. Kabala, Aviva; Z.A. Abassi, Zaid A.
    Year: 2024
    Citations: 2

 

E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Dr. E. Foy White-Chu | Medicine and Dentistry | Best Researcher Award

Geriatrician at OHSU, United States

Dr. E. Foy White-Chu, MD, CWSP, AGSF, is a distinguished geriatrician and wound care specialist at the VA Portland Health Care System (VAPHCS), where she serves as the Geriatric Fellowship Director and Wound Medical Director. She holds an Associate Professorship at Oregon Health & Science University and has extensive experience in geriatrics, wound care, and medical education. Dr. White-Chu has contributed significantly to the field through research, policy initiatives, and curriculum development, securing multiple grants for interdisciplinary wound care education. She has held leadership roles in professional organizations, including the Wound Healing Society and the American Geriatrics Society, and has served on national advisory committees. Her research, focusing on chronic wound care and skin failure in older adults, has been widely published in leading medical journals. Recognized with numerous awards, including Portland’s Top Doctors, she continues to shape healthcare practices through innovation, education, and evidence-based clinical advancements.

Professional Profile 

Education

Dr. E. Foy White-Chu earned her Doctor of Medicine (MD) degree from Baylor College of Medicine, where she developed a strong foundation in geriatric medicine and wound care. She then pursued a residency in Internal Medicine at the University of Texas Southwestern Medical Center, refining her clinical expertise in managing complex medical conditions. Driven by her passion for elderly care, she completed a Geriatrics Fellowship at the University of Texas Health Science Center at San Antonio, gaining specialized training in aging-related health issues, chronic wound care, and interdisciplinary care models. Throughout her education, Dr. White-Chu demonstrated a commitment to academic excellence, research, and medical education, laying the groundwork for her leadership in geriatric medicine. Her advanced training has enabled her to integrate evidence-based practices into clinical care, education, and policy development, contributing significantly to improving healthcare outcomes for older adults, particularly in chronic wound management and skin integrity preservation.

Professional Experience

Dr. E. Foy White-Chu is a distinguished geriatrician with extensive experience in clinical care, research, and medical education. She has held key positions in academic and healthcare institutions, specializing in geriatrics, wound care, and dermatological conditions in older adults. As an attending physician, she has provided expert care for elderly patients, focusing on chronic wound management and skin integrity. Her leadership roles have included faculty appointments where she has mentored medical students, residents, and fellows in geriatric medicine. Dr. White-Chu has contributed significantly to advancing wound care practices, integrating evidence-based approaches into clinical protocols. She has also been actively involved in research, publishing studies on pressure ulcers, dermatological health in aging populations, and best practices for geriatric care. Her dedication extends to policy advocacy, where she works to enhance healthcare standards for older adults. Through her expertise, she continues to shape the future of geriatric medicine and wound care.

Research Interest

Dr. E. Foy White-Chu’s research interests center on geriatrics, dermatology in aging populations, and wound care management. She is particularly focused on pressure ulcers, chronic wound healing, and skin integrity in elderly patients. Her work explores innovative approaches to preventing and treating wounds, emphasizing evidence-based interventions to improve patient outcomes. Dr. White-Chu also investigates the intersection of dermatological health and aging, studying conditions such as xerosis, pruritus, and other skin disorders prevalent in older adults. Additionally, she is committed to advancing geriatric care through research on best practices in long-term care settings, addressing quality-of-life concerns and improving healthcare protocols for aging populations. Her studies contribute to policy development and clinical guidelines, ensuring that older adults receive optimal care. Through her research, she continues to influence advancements in geriatric dermatology and wound management, bridging the gap between medical science and practical healthcare applications for the elderly.

Award and Honor

Dr. E. Foy White-Chu has received numerous awards and honors in recognition of her contributions to geriatrics, dermatology, and wound care management. Her dedication to improving skin integrity in aging populations has earned her accolades from professional medical associations and research institutions. She has been recognized for her excellence in clinical practice, innovative research, and leadership in geriatric healthcare. Dr. White-Chu has received distinguished service awards for her efforts in advancing wound care treatment and pressure ulcer prevention. Additionally, she has been honored for her contributions to medical education, mentoring future healthcare professionals, and enhancing best practices in long-term care settings. Her work has also been acknowledged through invitations to speak at national and international conferences, where she shares her expertise on geriatric dermatology and wound management. Through these honors, Dr. White-Chu’s impact on aging healthcare continues to be recognized and celebrated within the medical community.

Research Skill

Dr. E. Foy White-Chu possesses exceptional research skills, particularly in the fields of geriatrics, dermatology, and wound care. Her expertise lies in conducting clinical studies focused on skin integrity, pressure ulcer prevention, and advanced wound healing techniques in elderly patients. She has a strong background in designing and implementing evidence-based research methodologies, analyzing clinical data, and translating findings into practical healthcare solutions. Dr. White-Chu is skilled in interdisciplinary collaboration, working closely with healthcare professionals, researchers, and policymakers to enhance patient outcomes. Her ability to critically evaluate medical literature and contribute to peer-reviewed publications demonstrates her analytical and scientific writing proficiency. Additionally, she has experience in securing research funding, developing grant proposals, and leading innovative projects in aging-related skin care. Through her rigorous research approach, she continues to advance the understanding of geriatric dermatology, improving the quality of life for elderly individuals with chronic skin conditions.

Conclusion

Dr. E. Foy White-Chu is a highly accomplished researcher in geriatric medicine and wound care, with a strong academic, clinical, and research background. She is well-qualified for the Best Researcher Award, particularly in the domain of geriatric healthcare and wound management. Strengthening international collaborations, expanding research scope to include emerging technologies, and securing larger research grants could further enhance her competitiveness for this prestigious recognition.

Publications Top Noted

Title: Healing a Gap in Medical Education: Efficacy of a Wound Care Didactic Intervention
Authors: Sarah L. Becker, Elizabeth Foy White-Chu, Elena Paz Munoz, Martha A. Oberg, Alex Gerardo Ortega-Loayza
Year: 2025
Citations: 0